Drug Formulary Review articles from October 2007

Drug Formulary Review archives from October 2007

Successfully starting ambulatory clinical pharmacy services.
October 1, 2007... Successfully starting ambulatory clinical pharmacy services Pharmacists key to continuity of care and medication therapy outcomes Taking a step-by-step approach to implementing pharmacist-managed ambulatory clinics can lead to success....

Increasing staff reporting of pharmacy occurrences.
October 1, 2007... Increasing staff reporting of pharmacy occurrences Internal system opens safety discussion at all levels A pilot study at Dartmouth-Hitchcock Medical Center, a rural 353-bed tertiary care academic center in New Hampshire, found that a...

Statin adherence goes down with cost-sharing.
October 1, 2007... Statin adherence goes down with cost-sharing Requiring patients to help pay for their statin medications has a negative impact on adherence to the therapy, according to a study published in the April 10, 2007, issue of Circulation....

Abbreviations pose patient safety threat: JCAHO.(Clinical report)
October 1, 2007... Abbreviations pose patient safety threat: JCAHO A study reported in the Joint Commission Journal on Quality and Patient Safety says abbreviations used in health care are having an adverse effect on patient safety. Joint Commission officials...

New FDA Approvals.
October 1, 2007... New FDA Approvals FDA has approved new indications for Janssen's risperidone (Risperdal®) for treating schizophrenia in adolescents ages 13-17 and for the short-term treatment of manic or mixed episodes of bipolar 1 disorder in...

Rotigotine (Neupro[R]) Drug Evaluation.(Drug overview)
October 1, 2007... Rotigotine (Neupro®) Drug Evaluation By Caine Hillis, PharmD Candidate, Auburn (AL) University Rotigotine (Neupro®) is a new transdermal dopamine agonist. Mechanisms of Action *Rotigotine is a non-ergolinic aminotetralin...

CE Objectives/Questions.(continuing education)(Brief article)
October 1, 2007... CE Objectives This CE program will improve participants' ability to: *Compare the clinical efficacy and safety of one therapeutic agent over another used in the same setting. *Assess clinical trial data and explain how the results...